Scott R. Conley, Ph.D.
Scott is a managing associate at Frost Brown Todd LLC. He has experience with patent prosecution, portfolio management, and freedom to practice with an expertise in chemistry. Scott has represented a variety of clients, from small start-up companies to large multi-national corporations to university researchers.
Prior to joining Frost Brown Todd, Scott worked at Eastman Kodak as a synthetic organic chemist developing small molecules for use as photographic couplers in photographic film and materials for Organic Light Emitting Diodes (OLED). As a result, he is an inventor on ten U.S. patents. In graduate school, his research focused on the synthesis of natural products in the laboratory of K.C. Nicolaou at The Scripps Research Institute.
These experiences have provided Scott with an understanding of the process for developing and bringing new products to market. He communicates well with scientists.
Patent preparation and prosecution (U.S. and foreign)
Performed a non-infringement and invalidity analysis of a cancer chemoprotective compound from a brassica plant source that was used to assist the client in obtaining a favorable settlement of a patent infringement case.
Performed a non-infringement and invalidity analysis to advise the client of potential problems with an ANDA pharmaceutical filing.
Performed a non-infringement analysis of a water purification product which allowed the client to deal with a competitor's infringement allegation, without revealing the client's trade secrets.
Memberships & Affiliations
- American Chemical Society, Organic Chemistry Division and Chemistry and the Law Division
- Cincinnati Intellectual Property Law Association (CincyIP)
- American Intellectual Property Association (AIPLA)
- Supreme Court: Private Sales are Still Prior Art under the America Invents Act
- Federal Circuit Clarifies that Private Sales are Still Prior Art
- Federal Circuit clarifies what counts as an On-Sale Bar to Patentability
- Myriad Supreme Court Decision - cDNA, but not Isolated DNA, is Patent Eligible Subject Matter
- New Patent Strategies under the America Invents Act
- Advantages to Filing Patent Applications Before the America Invents Act becomes Fully Effective on March 16, 2013
- New Opportunities to Challenge Patents under the America Invents Act Coming in September
- Changes in the America Invents Act
Non-FBT Publications and Events
"Irrational Behavior, Hindsight, and Patentability: Balancing the 'Obvious to Try' Test with Unexpected Results," 51 IDEA 271, 2011
"The Children's Television Act: Reasons & Practice," 61 SYRACUSE L. REV. 49, 2010
"Efficient, Long-Lifetime OLED Host and Dopant Formulations for Full-Color Displays" Society for Information Display International Symposium; Long Beach, CA; May 22, 2007.
"Difluoroboron Bis(azinyl)amine Blue Dopants in OLED Devices" American Chemical Society National Fall Meeting; Philadelphia, PA; August 24, 2004.
"Synthesis and Photographic Effects of Thiosalicylic Coupling off Groups on Pyrazolo-(3,2,-c)-5-triazoles" National Organic Symposium; Bozeman, MT; June 2001.
"Total Synthesis of Everninomicin 13,384-1-Part 4: Explorations of Methodology; Stereocontrolled Synthesis of 1,1'-Disaccharides, 1,2-Seleno Migrations in Carbohydrates, and Solution- and Solid-Phase Synthesis of 2-Deoxy Glycosides and Orthoesters" Chemistry 2000, 6, 3166-3185.
"Total Synthesis of Everninomicin 13,384-1-Part 3: Synthesis of the DE Fragment and Completion of the Total Synthesis" Chemistry 2000, 6, 3149-3165.
"New Synthetic Technology for the Stereocontrolled Construction of 1,1'-Disaccharides and 1,1':1'',2-Trisaccharides. Synthesis of the FG Ring System of Everninomicin 13,384-1" J. Am. Chem. Soc. 1997, 119, 9057-9058.
"Total Synthesis of Brevetoxin B. 1. First Generation Strategies and New Approaches to Oxepane Synthesis" J. Am. Chem. Soc. 1995, 117, 10227-10238.